ChordNews
← All news

Lexicon Pharmaceuticals reports GAAP loss of $0.03 per share and $11.3M revenue, beating estimates

By ChordNews · First written (updated )

Comments 0

Summary

Lexicon Pharmaceuticals reported GAAP earnings per share of -$0.03, beating estimates by $0.03, and revenue of $11.3 million, beating estimates by $7.16 million, according to a Seeking Alpha breaking-news headline. The source article has no summary text, so no further details about the results are available.

This continues an earlier story: IDEAYA Biosciences reports GAAP EPS of -$1.22, missing by $0.03, while revenue of $10.24M beats by $2.66M

Timeline

  1. Seeking Alpha

    Source ↗

    Seeking Alpha reports in a breaking-news headline that Lexicon Pharmaceuticals posted GAAP EPS of -$0.03, beating by $0.03, and revenue of $11.3 million, beating by $7.16 million.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews